focus -WSS

focus

author：leisure time 2025-09-06 03:32:29 - browse：1497

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Drug repurposing or repositioning? The language matters
Next article： Europe sees delivery challenges ahead on Alzheimer's therapies

explore

WSS

J&J expands global access to TB drug amid advocacy campaign

Pregnant women don't need prenatal multivitamins, study concludes

Biden's 'march

Longer MASH drug regimen improved liver, Akero study finds

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

focus

focus

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Streamlined flu vaccines recommended by FDA advisory panel

Apple is now the first public company to be valued at $3 trillion

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Peter Hotez and the public health issue of online harassment

Medicare drug price negotiation continues, as pharma counteroffers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

How to save PrEP access — and even expand it

Medicare drug price negotiation hearing pits pharma v Biden admin

explore

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Celiac disease study examines precisely how gluten triggers injury

Microsoft's Peter Lee: Generative AI could help doctors be more human

Blood tests recalled over risk of missed heart attack diagnosis

Mike Pence clashes with Tucker Carlson in Iowa

Lack of health data on LGBTQ+ people has serious consequences

entertainment

explore

focus

knowledge